Cargando…
Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL
In current molecular medicine, next-generation sequencing (NGS) for transcript variant detection and multivariable analyses are valid methods for evaluating gene expression, cancer mechanisms, and prognoses of patients. We conducted RNA-sequencing on samples from patients with primary central nervou...
Autores principales: | Takashima, Yasuo, Kawaguchi, Atsushi, Sato, Ryuichi, Yoshida, Kenichi, Hayano, Azusa, Homma, Jumpei, Fukai, Junya, Iwadate, Yasuo, Kajiwara, Koji, Ishizawa, Shin, Hondoh, Hiroaki, Nakano, Masakazu, Ogawa, Seishi, Tashiro, Kei, Yamanaka, Ryuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620277/ https://www.ncbi.nlm.nih.gov/pubmed/31292525 http://dx.doi.org/10.1038/s41598-019-46473-5 |
Ejemplares similares
-
GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL
por: Takashima, Yasuo, et al.
Publicado: (2020) -
Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2018) -
MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2019) -
miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2020) -
Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2021)